Breakthrough T1D Celebrates Approval of First New Treatment for People with Type 1 Diabetes and Chronic Kidney Disease in 30 Years
September 17, 2026
September 17, 2026
NEW YORK, Sept. 17 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:
* * *
Breakthrough T1D Celebrates Approval of First New Treatment for People with Type 1 Diabetes and Chronic Kidney Disease in 30 Years
*
Breakthrough T1D applauds today's approval by the U.S. Food and Drug Administration (FDA) of the drug finerenone (Kerendia(tm)/Firialta(tm)) as the first . . .
* * *
Breakthrough T1D Celebrates Approval of First New Treatment for People with Type 1 Diabetes and Chronic Kidney Disease in 30 Years
*
Breakthrough T1D applauds today's approval by the U.S. Food and Drug Administration (FDA) of the drug finerenone (Kerendia(tm)/Firialta(tm)) as the first . . .